Patrick Innamarato

1.1k total citations
18 papers, 189 citations indexed

About

Patrick Innamarato is a scholar working on Immunology, Oncology and Biotechnology. According to data from OpenAlex, Patrick Innamarato has authored 18 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Patrick Innamarato's work include Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (9 papers). Patrick Innamarato is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (9 papers). Patrick Innamarato collaborates with scholars based in United States, India and Puerto Rico. Patrick Innamarato's co-authors include Shari Pilon‐Thomas, Amod A. Sarnaik, Krithika N. Kodumudi, Matthew Beatty, MacLean Hall, Amy Weber, Erica Royster, Satoshi Nemoto, Hao Liu and Doris Wiener and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Patrick Innamarato

18 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Innamarato United States 8 118 100 33 28 19 18 189
Rachael M. Zemek Australia 8 160 1.4× 152 1.5× 49 1.5× 20 0.7× 29 1.5× 15 240
Jessica S.W. Borgers Netherlands 8 115 1.0× 110 1.1× 44 1.3× 11 0.4× 18 0.9× 13 197
Tommaso Sconocchia Austria 10 116 1.0× 91 0.9× 86 2.6× 43 1.5× 9 0.5× 20 252
Soraya Zorro Manrique United States 4 112 0.9× 144 1.4× 50 1.5× 41 1.5× 9 0.5× 4 230
Shoubao Ma United States 8 243 2.1× 276 2.8× 71 2.2× 24 0.9× 16 0.8× 17 393
Siham Farhane France 6 105 0.9× 70 0.7× 25 0.8× 27 1.0× 20 1.1× 7 162
Tapan Agnihotri India 6 70 0.6× 209 2.1× 77 2.3× 27 1.0× 30 1.6× 7 300
Elham Beyranvand Nejad Netherlands 7 180 1.5× 203 2.0× 43 1.3× 15 0.5× 19 1.0× 7 280
Werner Frings United States 5 70 0.6× 114 1.1× 49 1.5× 15 0.5× 8 0.4× 10 211

Countries citing papers authored by Patrick Innamarato

Since Specialization
Citations

This map shows the geographic impact of Patrick Innamarato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Innamarato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Innamarato more than expected).

Fields of papers citing papers by Patrick Innamarato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Innamarato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Innamarato. The network helps show where Patrick Innamarato may publish in the future.

Co-authorship network of co-authors of Patrick Innamarato

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Innamarato. A scholar is included among the top collaborators of Patrick Innamarato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Innamarato. Patrick Innamarato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Yongliang, Amir A. Jazaeri, Ishan Patel, et al.. (2025). Feasibility of Manufacturing and Antitumor Activity of TIL for Advanced Endometrial Cancers. International Journal of Molecular Sciences. 26(15). 7151–7151. 1 indexed citations
2.
3.
Innamarato, Patrick, Nathan Gilbert, Álvaro de Mingo Pulido, et al.. (2024). 1032P Tumor-infiltrating lymphocytes with inducible membrane-tethered IL-12 cultured in optimized media exhibits superior anti-tumor activity. Annals of Oncology. 35. S695–S695. 1 indexed citations
4.
Zhang, Yongliang, et al.. (2023). 403 Tumor-infiltrating lymphocytes (TIL) with inducible and membrane-bound IL-12 exhibit superior antitumor activity in vitro. SHILAP Revista de lepidopterología. A452–A452. 1 indexed citations
5.
Harro, Carly M., Kimberly B. Sprenger, Ricardo A. Chaurio, et al.. (2023). Sézary syndrome originates from heavily mutated hematopoietic progenitors. Blood Advances. 7(18). 5586–5602. 5 indexed citations
6.
Martin, Alexandra, Subir Biswas, Jessica A. Mine, et al.. (2023). Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma. Gynecologic Oncology. 173. 114–121. 3 indexed citations
7.
Martin, Alexandra, Carmen M. Anadon, Subir Biswas, et al.. (2022). Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors. Molecular Cancer Therapeutics. 21(7). 1184–1194. 23 indexed citations
8.
Martin, Alexandra, Patrick Innamarato, John J. Powers, et al.. (2022). Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at unirradiated sites. Cancer Immunology Immunotherapy. 72(6). 1445–1460. 9 indexed citations
9.
10.
Martin, Alexandra, Subir Biswas, Jessica A. Mine, et al.. (2022). Olfactory receptor OR5V1 is an effective target for CAR T cells in ovarian cancer (207). Gynecologic Oncology. 166. S116–S116. 1 indexed citations
11.
Biswas, Subir, Alexandra Martin, Jessica A. Mine, et al.. (2022). CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors. The Journal of Immunology. 208(Supplement_1). 117.16–117.16. 1 indexed citations
12.
Innamarato, Patrick, et al.. (2021). Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors. BMC Cancer. 21(1). 756–756. 3 indexed citations
13.
Aydın, Ahmet Murat, Patrick Innamarato, Ali Hajiran, et al.. (2020). Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo. Journal for ImmunoTherapy of Cancer. 8(2). e001673–e001673. 7 indexed citations
14.
Innamarato, Patrick, Krithika N. Kodumudi, MacLean Hall, et al.. (2020). Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy. Molecular Therapy. 28(10). 2252–2270. 30 indexed citations
15.
Innamarato, Patrick, et al.. (2020). Reactive myelopoiesis and the onset of myeloid-mediated immune suppression: Implications for adoptive cell therapy. Cellular Immunology. 361. 104277–104277. 6 indexed citations
16.
Innamarato, Patrick, et al.. (2020). Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells. The Journal of Immunology. 205(10). 2893–2904. 8 indexed citations
17.
Poch, Michael, MacLean Hall, Krithika N. Kodumudi, et al.. (2018). Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer. OncoImmunology. 7(9). e1476816–e1476816. 35 indexed citations
18.
Liu, Hao, Patrick Innamarato, Krithika N. Kodumudi, et al.. (2016). Intralesional rose bengal in melanoma elicits tumor immunityviaactivation of dendritic cells by the release of high mobility group box 1. Oncotarget. 7(25). 37893–37905. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachael M. Zemek Breakdown of academic impact, for papers by Jessica S.W. Borgers Breakdown of academic impact, for papers by Tommaso Sconocchia Breakdown of academic impact, for papers by Soraya Zorro Manrique Breakdown of academic impact, for papers by Shoubao Ma Breakdown of academic impact, for papers by Siham Farhane Breakdown of academic impact, for papers by Tapan Agnihotri Breakdown of academic impact, for papers by Elham Beyranvand Nejad Breakdown of academic impact, for papers by Werner Frings
Rankless by CCL
2026